Dysprosium-containing cobalt sulfide nanoparticles as anticancer drug carriers
CONCLUSION: The ultrasmall nanoparticles possess a size suitable for drug delivery and are dispersed well in the aqueous medium. The release of the loaded 5-fluorouracil is slow and sustained. The anticancer activity of the drug-loaded nanocarrier shows an increase in efficacy, and the cytotoxicity is appreciable due to the controlled release. The nanocarriers show multi-functional characteristics, i.e., magnetic and NIR-absorbing, and are promising drug delivery agents.PMID:37592787 | DOI:10.2174/1567201821666230817122011
Source: Current Drug Delivery - Category: Drugs & Pharmacology Authors: Govindaraj Sri Varalakshmi Charan Singh Pawar Varnitha Manikantan Archana Sumohan Pillai Aleyamma Alexander Bose Allben Akash N Rajendra Prasad Israel V M V Enoch Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cobalt | Copper | Drugs & Pharmacology | Israel Health | Middle East Health | Nanotechnology